Green Cross Of S. Korea, Japan Drug Maker To Develop MRSA Drug
This article was originally published in PharmAsia News
Executive Summary
South Korea's Green Cross is poised to join with a Japanese partner to develop antibiotics targeted at treating the methicillin-resistant staphylococcus aureas "super bug" bacterium